HippoFi 43a.webp

Dr. Gail Naughton, world-renowned authority on the multi-billion dollar regenerative medicine market, joins HippoFi as Head of Regenerative Therapeutics and Commercialization

ByMokhtar

 

Scientist, inventor, business expert and holder of more than 140 patents will advance PUR Biologics’ regenerative therapeutic patent portfolio to address unmet needs in the $200 billion osteoarthritis, pain and cartilage and spine regeneration markets.

IRVINE CA., November 7, 2023 – OrthoSpineNews – HippoFi, Inc. (OTCPK: ORHB) is proud to announce the appointment of the world’s foremost authority and pioneer in regenerative medicine, Gail Naughton, MBA, Ph.D, as the “Head of Regenerative Therapeutics and Commercialization.”

Recognized worldwide, Dr. Naughton was awarded the 27th annual National Inventor of the Year by the Intellectual Property Owners Association in honor of her groundbreaking work in tissue engineering and regenerative medicine. Dr. Naughton has been a driving force in regenerative medicine for more than 35 years and, as founder of Advanced Tissue Sciences and Histogen, has a proven track record in monetizing important cell-based therapies and bioengineered tissue technologies. Although it is known for taking four products from concept, through FDA approval, to market launch; and taken two companies to a NASDAQ stock exchange listing, she has had broad success in commercializing major brands that are still widely sold today by establishing partnerships and strategic business alliances with several industry giants, including: NYSE Company Allergan (recently purchased by AbbVie for $63B), NYSE company Smith & Nephew, NYSE company Medtronic, and Inamed Corporation (also owned by AbbVie).

“I am thrilled and honored to join the visionary HippoFi team and work together to transform healthcare by developing and commercializing life-changing regenerative medicine solutions for unmet medical needs,” said Gail Naughton, MBA, Ph.D – Head of Regenerative Therapeutics and Commercialization.

Dr. Naughton has served on the board of directors of several public and private companies since 1988. She currently serves as chair of the board of directors of the La Jolla Institute, executive chair of BioHIP, a member of the boards of NASDAQ, Therapeutics MD, and NYSE company CelSci, and serves on the boards of International Business and Fowler College of Business at SDSU. In addition to serving for eleven years on the board of the Toronto-based, publicly funded Center for the Commercialization of Regenerative Medicine (CCRM), she also served for several years on the bioengineering advisory board of John Hopkins, UCSD, MIT and Georgia Tech. Dr. Naughton served as dean of the College of Business Administration at SDSU from 2002 to 2011 and received her Ph.D. and MS from NYU Medical Center and an MBA from UCLA.

“Dr. Naughton is a globally recognized, accomplished entrepreneur with many proven track records, visionary talent and unparalleled experience that will be extremely valuable to HippoFi’s continued growth and success,” said CJ Wiggins, MBA – Founder, Executive Chairman and CEO of HippoFi. “As a pioneer in our industry, adding her expertise to our experienced team not only helps us quickly commercialize and monetize our patented technologies, but also validates the tremendous market value of our patent portfolio and strengthens HippoFi as a leader in the market for regenerative therapies. ”

About PUR Biologics
PUR Biologics, a wholly owned subsidiary of HippoFi, Inc. (OTCPK: ORHB), is a leading biologics company committed to supporting surgeons and hospitals in providing the best care to their patients. PUR Biologics’ full line of biological products currently includes: advanced allografts and demineralized extracellular matrices (dECM), innovative synthetic solutions, cellular-derived tissues and a future of next-generation regenerative stem cell and growth factor-driven therapies for the treatment of osteoarthritis and cartilage regeneration.

About HippoFi, Inc.
HippoFi, Inc. delivers its breakthrough healthcare innovations through an extensive sales channel network while deploying first-to-market solutions in the multi-billion dollar biotech, fintech and artificial intelligence (AI) markets. HippoFi consists of three segments: Regenerative Therapeutics, Digital Payments and AI, which use the same customer channels to commercialize solutions, increase revenue and improve patient outcomes.

HippoFi, Inc. is publicly traded under the symbol: ORHB and is headquartered in Irvine, California. For more information, please visit: www.HippoFi.com and www.PURbiologics.com.

Contact
HippoFi, Inc.
949-323-2330
info@hippofi.com

Source link

Related Articles

Knee replacement infection signsHow long does knee replacement lastBest ice machine for knee surgery (Game Ready, Polar Care)Best knee pillow for side sleepers

Similar Posts

  • Aclarion Announces Achievement of Goal to Enroll 10 Key Opinion Leaders (KOLs) in Spine Surgery to Support Adoption of Nociscan

    ByMokhtar

      Recruiting a panel of leading KOL surgeons who believe Nociscan can improve the diagnosis and treatment of discogenic low back pain is a critical step in establishing Nociscan as the standard of care. Aclarion’s KOL panel represents spine surgeons at some of the largest and most influential academic centers and private practices in the…

  • |

    Winning combination for sports-related shoulder injuries

    ByMokhtar

    Initiating a robust exercise program earlier after surgery can prevent patients with dislocated shoulders from re-injuring and allow them to return to sports more quickly. Researchers from the University of Adelaide spent three years analyzing evidence from 3,600 existing studies and concluded that a tailored exercise program starting three to six weeks after surgery is…

  • |

    Failed knee replacement symptoms

    ByMokhtar

    What if the relief you expected after your joint procedure never arrives? This unsettling question faces a small percentage of individuals each year. While statistics show that 85% to 90% of patients enjoy successful outcomes for 15 to 20 years after their initial knee replacement surgery, some do not. failed knee replacement symptoms We understand that persistent discomfort following this major operation can be a source of deep frustration. It can severely limit your mobility and daily life. Our guide is here to shed light on the various signs that may indicate your implant is not performing as designed. Identifying these indicators early is critically important. It ensures you get the right medical attention and potential intervention from a qualified specialist. If you experience persistent pain and stiffness, understanding the next steps is vital. We will walk you through common warning signs, the diagnostic process, and the treatment paths available to restore your comfort and movement. Key Takeaways Most knee replacement procedures are highly successful for many years. Recognizing early warning signs of a problem is crucial for your health. Specialized care models, like the one at University of Utah Hospital, combine expert teams for complex cases. Persistent pain, swelling, or instability after recovery should not be ignored. Several effective treatment options exist to address implant issues. Early consultation with an orthopedic surgeon can lead to better outcomes. Your long-term mobility and quality of life are the ultimate goals. Understanding Knee Replacement Surgery Modern orthopedic medicine offers a reliable solution for severe joint damage through artificial joint implantation. This procedure aims to restore comfortable movement when natural cartilage wears down. knee replacement surgery components How Knee Replacements Work During this operation, surgeons remove damaged joint surfaces. They replace them with precisely engineered metal and plastic components. These artificial parts are designed to glide smoothly. They mimic your joint’s natural motion, reducing discomfort. Fixation Method How It Works Key Consideration Cemented Fixation Special bone cement bonds the implant directly to your bone. Provides immediate, strong stability after the operation. Biologic Fixation The bone grows into a porous coating on the device over time. Creates a durable, long-term bond without cement. Surgeon’s Choice The method is selected based on your bone quality and age. Each technique has specific advantages for different situations. Long-Term Expectations and Implant Lifespan Most modern devices are engineered for durability. A typical lifespan ranges from 15 to 20 years. “The longevity of a joint implant depends on multiple factors, including the patient’s activity level and overall bone health.” We emphasize that these components are not indestructible. They experience natural wear from daily use over time. Regular monitoring helps ensure your artificial joint functions well for as long as possible. Your activity choices and general health play significant roles. Recognizing Failed Knee Replacement Symptoms When an artificial joint doesn’t function as intended, your body sends distinct signals that demand attention. Learning to identify these signs is crucial for your long-term health and mobility. Persistent Pain and Swelling Persistent pain in the knee joint that lingers long after the typical recovery period is a primary indicator. This pain isn’t normal soreness. It often presents as a deep, constant ache. Swelling around the knee joint that refuses to fade with rest is another red flag. Persistent pain and swelling are common companions. They can suggest underlying issues like inflammation or component loosening. Instability and Changes in Joint Function A feeling of instability, where your leg might buckle, is alarming. This instability often feels like the joint is giving way when you put weight on it. You might also notice a noticeable decline in how well it moves. Stiffness, developing a limp, or hearing odd popping noises are critical functional changes. We encourage you to monitor these signs closely. They are the primary indicators that your implant may require further clinical assessment. Common Causes of Knee Replacement Failure…

  • |

    September 2023 Schedule — Bone Talk

    ByMokhtar

    Bone Buddies Virtual Support Group: September 2023 schedule Join the Bone Buddies Online Virtual Support Group this September! Weekly sessions cover topics ranging from diet, exercise, treatment and more! Saturday, September 16 at 10am CT: Bone Buddies presentation on epigenetics and low bone density Thursday, September 21 at 2:00 PM CT: Healthy Eating Session Saturday,…

  • | |

    What is a patient-reported outcome measure or PROM and the KOOS?

    ByMokhtar

      Image by FatCamera from Canva Pro Are you recovering from a knee injury or knee surgery and are you asked to complete a questionnaire, the so-called Knee Injury and Osteoarthritis Outcome Score (KOOS)? This blog highlights the purpose of these questionnaires and explains what the KOOS is and how it is relevant to you…

  • John Booth retires as CEO of Spineology Inc.

    ByMokhtar

      Brian Snider appointed new CEO SAINT PAUL, Minn., November 9, 2023–(BUSINESS WIRE)–Spineology Inc. (“Spineology” or the “Company”), the leader in ultra-minimally invasive spine surgery, today announced that John Booth will resign from his position as Chief Executive Officer of Spineology, effective November 10, 2023. The Board of Directors has selected Brian Snider as the…

Leave a Reply

Your email address will not be published. Required fields are marked *